Valeur Intrinsèque du S&P et Nasdaq Contactez-nous

Amylyx Pharmaceuticals, Inc. AMLX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
62/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$22.00
+30%

Il y a eu 50 transactions d'initiés récentes enregistrées pour Amylyx Pharmaceuticals, Inc. (AMLX), dont 17 achats et 31 ventes. Le total des achats d'initiés s'élève à $19.97M et le total des ventes d'initiés à $6.08M.

Les initiés notables ayant une activité récente comprennent Frates James M, Bedrosian Camille L, Klee Justin B.. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — AMLX

Date Nom Rôle Type de Transaction Actions Prix Moyen Valeur Actions détenues
2026-03-05 Frates James M Chief Financial Officer Attribution de RSU 143,985 $14.10 $2.03M 143,985
2026-03-05 Bedrosian Camille L Chief Medical Officer Attribution de RSU 143,985 $14.10 $2.03M 143,985
2026-03-05 Klee Justin B. Co-chief Executive Officer Attribution de RSU 373,295 $14.10 $5.26M 373,295
2026-03-05 Cohen Joshua B Co-chief Executive Officer Attribution de RSU 373,295 $14.10 $5.26M 373,295
2026-03-05 Mazzariello Gina Chief Legal Officer Attribution de RSU 111,990 $14.10 $1.58M 111,990
2026-03-02 Frates James M Chief Financial Officer Vente Informative 7,909 $14.52 $114.85K 165,638
2026-03-02 Bedrosian Camille L Chief Medical Officer Vente Informative 6,461 $14.58 $94.21K 169,295
2026-03-02 Klee Justin B. Co-chief Executive Officer Vente Informative 29,282 $14.47 $423.76K 3,334,616
2026-03-02 Cohen Joshua B Co-chief Executive Officer Vente Informative 29,282 $14.48 $424.12K 3,334,683
2026-03-02 Mazzariello Gina Chief Legal Officer Vente Informative 6,844 $14.52 $99.38K 134,430
2026-02-23 Mazzariello Gina Chief Legal Officer Vente Informative 3,419 $14.14 $48.35K 141,274
2026-02-02 Frates James M Chief Financial Officer Vente Informative 3,557 $14.65 $52.1K 173,547
2026-02-02 Klee Justin B. Co-chief Executive Officer Vente Informative 15,500 $14.69 $227.62K 3,363,898
2026-02-02 Cohen Joshua B Co-chief Executive Officer Vente Informative 15,500 $14.68 $227.59K 3,363,965
2026-02-02 Mazzariello Gina Chief Legal Officer Vente Informative 3,448 $14.65 $50.52K 144,693
2026-01-16 Klee Justin B. Co-chief Executive Officer Exercice d'Options (Vente) 2,847 $7.57 $21.55K -
2026-01-16 Cohen Joshua B Co-chief Executive Officer Exercice d'Options (Vente) 2,818 $7.57 $21.33K -
2026-01-15 Klee Justin B. Co-chief Executive Officer Exercice d'Options (Vente) 197,153 $7.57 $1.49M 2,847
2026-01-15 Cohen Joshua B Co-chief Executive Officer Exercice d'Options (Vente) 197,182 $7.57 $1.49M 2,818
2026-01-12 Milne George M Jr Director Don (Donné) 17,780 - - 812,881
2026-01-06 Frates James M Chief Financial Officer Vente Informative 3,326 $11.11 $36.95K 177,104
2026-01-06 Klee Justin B. Co-chief Executive Officer Vente Informative 7,715 $11.09 $85.59K 3,317,586
2026-01-06 Cohen Joshua B Co-chief Executive Officer Vente Informative 7,715 $11.09 $85.6K 3,317,632
2025-12-23 Firestone Karen Director Achat Informatif 8,100 $12.45 $100.85K 63,100
2025-12-01 Bedrosian Camille L Chief Medical Officer Vente Informative 6,580 $14.35 $94.42K 175,756
2025-09-30 Frates James M Chief Financial Officer Vente Informative 10,558 $14.65 $154.65K 280,430
2025-09-30 Bedrosian Camille L Chief Medical Officer Vente Informative 12,039 $14.58 $175.52K 182,336
2025-09-30 Klee Justin B. Co-chief Executive Officer Vente Informative 200 $15.01 $3K 3,325,301
2025-09-30 Cohen Joshua B Co-chief Executive Officer Vente Informative 200 $15.00 $3K 3,325,347
2025-09-30 Mazzariello Gina Chief Legal Officer Vente Informative 8,828 $14.58 $128.67K 148,141
2025-08-13 Mazzariello Gina Chief Legal Officer Vente Informative 15,000 $8.34 $125.05K 156,969
2025-08-12 Mazzariello Gina Chief Legal Officer Vente Informative 15,000 $8.07 $121.1K 171,969
2025-06-05 Milne George M Jr Director Attribution de RSU 25,000 $5.05 $126.25K 25,000
2025-06-05 Quimi Daphne Director Attribution de RSU 25,000 $5.05 $126.25K 25,000
2025-06-05 Fonteyne Paul R. Director Attribution de RSU 25,000 $5.05 $126.25K 25,000
2025-06-05 Firestone Karen Director Attribution de RSU 25,000 $5.05 $126.25K 25,000
2025-06-05 Zeiher Bernhardt G Director Attribution de RSU 25,000 $5.05 $126.25K 25,000
2025-05-22 Mazzariello Gina Chief Legal Officer Don (Donné) 1,000 - - 186,969
2025-03-31 Frates James M Chief Financial Officer Vente Informative 10,896 $3.47 $37.81K 290,988
2025-03-31 Bedrosian Camille L Chief Medical Officer Vente Informative 12,425 $3.47 $43.08K 194,375
2025-03-31 Klee Justin B. Co-chief Executive Officer Vente Informative 21,490 $3.46 $74.45K 3,355,276
2025-03-31 Cohen Joshua B Co-chief Executive Officer Vente Informative 21,490 $3.47 $74.48K 3,355,280
2025-03-31 Mazzariello Gina Chief Legal Officer Vente Informative 9,192 $3.48 $31.95K 187,969
2025-03-20 Zeiher Bernhardt G Director Achat Informatif 10,000 $3.70 $37.01K 10,000
2025-03-06 Frates James M Chief Financial Officer Attribution de RSU 102,630 $3.61 $370.49K 102,630
2025-03-06 Bedrosian Camille L Chief Medical Officer Attribution de RSU 102,630 $3.61 $370.49K 102,630
2025-03-06 Klee Justin B. Co-chief Executive Officer Attribution de RSU 270,177 $3.61 $975.34K 270,177
2025-03-06 Cohen Joshua B Co-chief Executive Officer Attribution de RSU 270,177 $3.61 $975.34K 270,177
2025-03-06 Mazzariello Gina Chief Legal Officer Attribution de RSU 95,777 $3.61 $345.75K 95,777
2025-03-03 Klee Justin B. Co-chief Executive Officer Vente Informative 4,595 $3.15 $14.48K 3,196,648
Informatif — transaction sur marché ouvert (la plus significative) Non informatif (achat) — récompense, exercice d'option, conversion Non informatif (vente) — retenue fiscale, vente à l'acquisition Neutre — don, fiducie, expiration
Contactez-nous
🎓
SharesGrow Académie
Apprenez à calculer la Valeur Intrinsèque et trouver des actions sous-évaluées.
Sessions hebdomadaires en direct
Envoyez-nous un message